PREVEST DENPRO Financial Statement Analysis
|
||
|
The Revenues of PREVEST DENPRO have decreased by 0.00% YoY .
The Earnings Per Share (EPS) of PREVEST DENPRO has increased by 12.57 % YoY. |
||
PREVEST DENPRO Last 5 Annual Financial Results
[BOM: 543363]
| Consolidated | Mar2025 | Mar2024 |
|---|---|---|
| Revenues | ₹56 Cr | ₹56 Cr |
| Expenses | ₹36 Cr | ₹36 Cr |
| Operating Profit (Excl OI) | ₹20 Cr | ₹20 Cr |
| Other Income | ₹2.86 Cr | ₹2.86 Cr |
| Interest | ₹0.21 Cr | ₹0.21 Cr |
| Depreciation | ₹1.28 Cr | ₹1.28 Cr |
| Profit Before Tax | ₹21 Cr | ₹21 Cr |
| Profit After Tax | ₹16 Cr | ₹16 Cr |
| Consolidated Net Profit | ₹16 Cr | ₹16 Cr |
| Earnings Per Share (Rs) | ₹15.13 | ₹13.44 |
| PAT Margin (%) | 27.95 | 27.59 |
| ROE(%) | 18.70 | 18.21 |
| ROCE(%) | 25.24 | 24.42 |
| Total Debt/Equity(x) | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 475.2 Cr |
| Revenue (TTM) | : | ₹ 71.3 Cr |
| Net Profit(TTM) | : | ₹ 19.8 Cr |
| EPS (TTM) | : | ₹ 16.5 |
| P/E (TTM) | : | 24.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PREVEST DENPRO | -5.7% | -5.1% | -14.4% |
| LENSKART SOLUTIONS | -0% | -11.8% | NA |
| POLY MEDICURE | -13% | -3.1% | -38.2% |
| 3B BLACKBIO DX | 4.9% | 3.6% | -21.1% |
| LAXMI DENTAL | -2.6% | -0.2% | -50.2% |
| NURECA | -0.3% | 3.1% | 11.7% |
PREVEST DENPRO Revenues
[BOM: 543363]
| Y-o-Y | 0.00 % |
| 5 Yr CAGR | 0.00 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹56 Cr | 0.00 | |
| Mar2024 | ₹56 Cr | - | |
PREVEST DENPRO Operating Profit
[BOM: 543363]
| Y-o-Y | 0.00 % |
| 5 Yr CAGR | 0.00 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹20 Cr | 0.00 | |
| Mar2024 | ₹20 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 0.00 % |
| 5 Yr CAGR | 0.00 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 35.55% | 0.00 | |
| Mar2024 | 35.55% | - | |
PREVEST DENPRO Profit After Tax
[BOM: 543363]
| Y-o-Y | 0.00 % |
| 5 Yr CAGR | 0.00 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | 0.00 | |
| Mar2024 | ₹16 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 1.30 % |
| 5 Yr CAGR | 1.30 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 27.95 % | 1.30 | |
| Mar2024 | 27.59 % | - | |
PREVEST DENPRO Earnings Per Share (EPS)
[BOM: 543363]
| Y-o-Y | 12.57 % |
| 5 Yr CAGR | 12.57 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹15 | 12.57 | |
| Mar2024 | ₹13 | - | |
PREVEST DENPRO Return on Capital Employed (ROCE)
[BOM: 543363]
| Y-o-Y | 3.36 % |
| 5 Yr CAGR | 3.36 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 25.24% | 3.36 | |
| Mar2024 | 24.42% | - | |
PREVEST DENPRO Share Price vs Sensex
| Current Share Price | : | ₹396.0 |
| Current MarketCap | : | ₹ 475.2 Cr |
| Updated EOD on | : | May 18,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PREVEST DENPRO | -5.7% |
-5.1% |
-14.4% |
| SENSEX | 0.9% |
-3.6% |
-7.3% |
PREVEST DENPRO related INDICES
You may also like the below Video Courses
FAQ about PREVEST DENPRO Financials
How the annual revenues of PREVEST DENPRO have changed ?
The Revenues of PREVEST DENPRO have decreased by 0.00% YoY .
How the Earnings per Share (EPS) of PREVEST DENPRO have changed?
The Earnings Per Share (EPS) of PREVEST DENPRO has increased by 12.57 % YoY .
|
Intrinsic Value of LENSKART SOLUTIONS LTD Intrinsic Value of POLY MEDICURE LTD Intrinsic Value of 3B BLACKBIO DX LTD Intrinsic Value of LAXMI DENTAL LTD Intrinsic Value of PREVEST DENPRO LTD |
LENSKART SOLUTIONS LTD vs POLY MEDICURE LTD vs 3B BLACKBIO DX LTD
LAXMI DENTAL LTD vs PREVEST DENPRO LTD vs